Clinical Trial Update: A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase II clinical trial of KDT-3594 for Parkinson's disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KDT-3594

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING